How an experimental drug reverses fatty liver disease
A drug in clinical trials as a treatment for metabolic dysfunction-associated steatotic liver disease (MASLD) works with a one-two punch that shuts down triglyc
Source: newswise.com
Stay updated with breaking news from Arteriosclerosis Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A drug in clinical trials as a treatment for metabolic dysfunction-associated steatotic liver disease (MASLD) works with a one-two punch that shuts down triglyc
A drug in clinical trials as a treatment for metabolic dysfunction-associated steatotic liver disease (MASLD) works with a one-two punch that shuts down triglyc